SCHEMBL6091445

SCHEMBL6091445

CCCCC(C)(c1ccc(OC)cc1)c1c[nH]c2c(C)cccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAT1 O14929 2/20 0.37
EP300 Q09472 2/20 0.37
NR4A2 P43354 1/20 0.36
HTR2A P28223 1/20 0.35
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TRIM24 O15164 1/20 0.34
TRIM33 Q9UPN9 1/20 0.34
SOS2 Q07890 1/20 0.34
BRPF1 P55201 1/20 0.33
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
KIF11 P52732 1/20 0.32
KCNH2 Q12809 1/20 0.32
ESR1 P03372 1/20 0.32
AR P10275 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
HDAC3 O15379 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6090952 0.93 HAT1 (0.38) HAT1EP300NR4A2HTR2AMAPT
SCHEMBL6091442 0.88 NR4A2 (0.39) HAT1EP300NR4A2HTR2AMAPT
SCHEMBL6089116 0.81 MAPT (0.39) MAPTESR1ALDH1A1TSHRMEN1
SCHEMBL6092231 0.81 KIF11 (0.34) HTR2AMAPTKIF11KCNH2ESR1
SCHEMBL6088618 0.79 HTR2A (0.40) NR4A2HTR2AMAPTSMN1; SMN2NPSR1
SCHEMBL6088671 0.79 AR (0.40) NR4A2HTR2AMAPTSMN1; SMN2NPSR1
SCHEMBL6090884 0.77 HAT1 (0.41) HAT1EP300NR4A2HTR2AMAPT
SCHEMBL6091641 0.74 AR (0.51) HAT1EP300NR4A2HTR2AMAPT
SCHEMBL5957318 0.74 ALDH1A1 (0.45) MAPTCNR1CNR2KIF11KCNH2
SCHEMBL27682917 0.70 HTR2A (0.41) NR4A2HTR2AMAPTSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors ELI LILLY AND COMPANY (US) 2006-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors NR3C2, NR5A1, MC2R HAT1 2516/4885EP300 470/4885NR4A2 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.